Marksans Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '24
Sep '24
Jun '24
Mar '24
Dec '23
Total Qtr Revenue cr
709.70
652.98
605.57
576.54
590.93
Other Income Qtr Cr27.8511.0614.9516.534.80
Operating Revenues Qtr681.85641.92590.62560.01586.13

*All values are in Cr.

Operating Expenses Qtr
543.08
506.24
462.18
450.37
453.10
Operating Profit Qtr
138.76
135.68
128.44
109.64
133.02
EBIDT Qtr Cr
166.61
146.74
143.38
126.17
137.82
Depreciation Qtr
20.69
19.51
20.44
21.06
22.00
Net Profit Qtr
104.56
96.72
88.75
78.29
83.24
Basic EPS Qtr
2.31
2.13
1.96
1.73
1.84
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -